Distinct demographics for persistent A-fib from onset

March 24, 2016

(HealthDay)—Patients with persistent atrial fibrillation (AF) from the onset (PsAFonset) have distinct demographics and poorer clinical outcome, according to a study published online March 23 in JACC: Clinical Electrophysiology.

Han S. Lim, M.B.B.S., Ph.D., from the Hôpital Cardiologique du Haut-Lévêque in Bordeaux, France, and colleagues enrolled referred for PsAF ablation from three centers. They compared 129 consecutive patients with PsAFonset with 231 patients with PsAF that progressed from paroxysmal AF. In addition, they characterized AF drivers using noninvasive mapping in 90 patients (30 PsAFonset and 60 controls).

The researchers found that patients with PsAFonset were younger, more obese, more often males, more often had hypertension, and had larger left and right atria. PsAFonset patients had a shorter AF-cycle-length, higher degree of fractionation, and lower endocardial voltage. A significantly higher number of reentrant driver regions and extra-pulmonary vein regions harboring reentrant drivers was seen among PsAFonset patients; in contrast, more focal driver regions were seen among controls. The PsAFonset group had lower acute AF termination rate. Patients with PsAFonset had significantly higher AF, atrial tachycardia (AT), and AF/AT recurrence rates during a mean follow-up of 17 ± 11 months from the last procedure.

"The findings highlight the importance of defining criteria for early detection of atrial substrate disease," the authors write.

Several authors disclosed financial ties to the pharmaceutical, medical device, and medical technology industries.

Explore further: Genotype doesn't predict A-fib in hypertrophic cardiomyopathy

More information: Full Text (subscription or payment may be required)

Related Stories

Genotype doesn't predict A-fib in hypertrophic cardiomyopathy

March 21, 2016
(HealthDay)—For patients with hypertrophic cardiomyopathy (HC), genotype does not predict onset or severity of atrial fibrillation (AF), according to a study published in the April 1 issue of The American Journal of Cardiology.

Age impacts outcomes after ablation for atrial fibrillation

October 16, 2015
(HealthDay)—Age significantly impacts long-term outcomes after catheter ablation for atrial fibrillation (AF), according to a study published online Oct. 7 in the Journal of Cardiovascular Electrophysiology.

A-fib recurrence common five years after ablation

April 17, 2015
(HealthDay)—Most patients with atrial fibrillation (AF) and systolic heart failure who undergo ablation have AF recurrence at five years, according to a study published in the April issue of the Journal of Cardiovascular ...

Multiple repeat procedures seem beneficial in A-fib recurrence

May 4, 2015
(HealthDay)—Most patients experience benefit after three or more catheter ablation procedures for atrial fibrillation (AF), according to a study published in the April issue of the Journal of Cardiovascular Electrophysiology.

In ablation for persistent atrial fibrillation, 'less may be more'

September 2, 2014
In patients with persistent atrial fibrillation (AF) - an abnormal heart rhythm – treating only the pulmonary veins with a procedure called ablation resulted in reasonable outcomes without the need to treat other areas ...

Flu vaccine shows promise for reducing risk of influenza-associated atrial fibrillation

February 2, 2016
Influenza is significantly associated with an increased risk of new-onset atrial fibrillation, which could be reduced through influenza vaccination, according to new findings reported HeartRhythm.

Recommended for you

Heart researchers develop a new, promising imaging technique for cardiac arrhythmias

February 22, 2018
Every five minutes in Germany alone, a person dies of sudden cardiac arrest or fibrillation, the most common cause of death worldwide. This is partly due to the fact that doctors still do not fully understand exactly what ...

Scientists use color-coded tags to discover how heart cells develop

February 22, 2018
UCLA researchers used fluorescent colored proteins to trace how cardiomyocytes—cells in heart muscle that enable it to pump blood—are produced in mouse embryos. The findings could eventually lead to methods for regenerating ...

Beetroot juice supplements may help certain heart failure patients

February 22, 2018
Beetroot juice supplements may help enhance exercise capacity in patients with heart failure, according to a new proof-of-concept study. Exercise capacity is a key factor linked to these patients' quality of life and even ...

'Beetroot pill' could help save patients from kidney failure after heart X-ray

February 22, 2018
Beetroot may reduce the risk of kidney failure in patients having a heart x-ray, according to research led by Queen Mary University of London.

Women once considered low risk for heart disease show evidence of previous heart attack scars

February 20, 2018
Women who complain about chest pain often are reassured by their doctors that there is no reason to worry because their angiograms show that the women don't have blockages in the major heart arteries, a primary cause of heart ...

Can your cardiac device be hacked?

February 20, 2018
Medical devices, including cardiovascular implantable electronic devices could be at risk for hacking. In a paper publishing online today in the Journal of the American College of Cardiology, the American College of Cardiology's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.